We looked past the sales page at who sells GenF20 Plus, what its one clinical trial actually found, and how the refund policy works.
GenF20 Plus is a real product from an established company, Leading Edge Health, with a written 67-day guarantee, so it is not a scam in the usual sense. But its one published trial did not show a significant IGF-1 increase versus placebo across all participants. The advertised 28% rise comes from an after-the-fact analysis of people over 40, and the study never measured growth hormone itself.
GenF20 Plus is sold by Leading Edge Health, the same company behind VigRX Plus, HyperGH 14x and a long list of other supplements. The official site lists Leading Edge Health Inc. at an office address in Victoria, British Columbia, and Leading Edge Health Ltd. in Limassol, Cyprus. Its sister sites also list LEM Processing LLC in Las Vegas, Nevada, which handles payments. Those are real, published addresses, and the company has a toll-free support line and email.
Leading Edge Health Inc. has a Better Business Bureau profile showing an A+ rating and accreditation since August 2016. The few public reviews visible on that profile are negative, mostly about refunds and orders that did not arrive. That is a common pattern for companies shipping internationally, and a reminder to keep receipts and tracking numbers.
So on the most basic question, yes: GenF20 Plus is a real product from a real, established company. You will get what you pay for in the sense that a box arrives. Whether what is inside does what the marketing implies is a different question.
The official site's headline claim is that GenF20 Plus "increased IGF-1 levels by 28% after just 12 weeks." IGF-1 is a hormone the liver makes in response to growth hormone, so it is often used as a stand-in measure. The claim comes from a real published trial, but the 28% figure leaves out most of the story.
| Detail | What the paper reports |
|---|---|
| Citation | Sonawane N, Kale V, Erande S, Chaudhary J. Open Access Journal of Clinical Trials, 2015; 7:35-42 |
| Design | Randomized, double-blind, placebo-controlled, five outpatient centers in India |
| Who took part | Adults aged 35 to 65 with at least two of: poor memory, low libido, low energy, poor sleep |
| Completed | 61 of 70 randomized (31 GenF20 Plus, 30 placebo) |
| Dose and length | Two tablets plus 2 mL liquid under the tongue, twice daily, for 12 weeks |
| Main result, all participants | IGF-1 rose 13.46 ng/mL on GenF20 Plus vs. 6.35 ng/mL on placebo. Not statistically significant. |
| Where the "28%" comes from | A post hoc analysis of participants aged 40 and over, adjusted for baseline differences |
| Other outcomes | No significant difference from placebo in body fat, lean mass, BMI, waist, memory, libido, energy or sleep |
| Funding | Run by Vedic Lifesciences with financial support from DM Contact Management |
On its main measure, across everyone who took part, GenF20 Plus did not beat placebo. The only statistically significant IGF-1 result came after the researchers split participants by age after the fact (the cutoff of 40 was chosen from the groups' mean and median ages) and then adjusted for the fact that the two groups started at different IGF-1 levels. Even in the over-40 group, the unadjusted comparison was not significant.
Post hoc subgroup findings are useful for deciding what to test next. They are not proof. The more ways you slice a small dataset, the more likely one slice shows a "significant" result by chance.
The authors were fairly candid. They describe it as a first exploratory study, say no sample size calculation was done and the target of 60 completers was "arbitrarily chosen," and write that the product "may not have delivered the projected efficacy results." The study also measured IGF-1, not growth hormone itself, and the official site's own footnote acknowledges it "did not measure for a direct increase in HGH." Every other benefit people care about, from body composition to energy and sleep, showed no difference from placebo.
The funding is not a reason to dismiss the study, but it is worth knowing. The paper says the authors had no competing interests, while the trial was paid for by DM Contact Management. We could not independently confirm that company's relationship to Leading Edge Health. Our deeper look at the GenF20 Plus clinical evidence goes through the ingredient research too.
We could not find the GenF20 Plus trial listed in PubMed. The journal it appeared in, the Open Access Journal of Clinical Trials from Dove Medical Press, is listed in the National Library of Medicine catalog as not currently indexed for MEDLINE. The publisher labels it a peer-reviewed article, and it gives a trial registration number with India's clinical trials registry. We did not find any other published trial of GenF20 Plus, and no independent replication.
There is also history in this category. In 2005 the Federal Trade Commission reached what it called the largest monetary judgment in an FTC health fraud case against marketers of HGH pills and sprays (not Leading Edge Health). The FTC said it knew of no competent and reliable scientific evidence that pills or sprays raise growth hormone levels or deliver anti-aging benefits. That was 2005 and other products, but it is the regulatory backdrop for any "HGH releaser."
As of October 2026, the official guarantee page offers a refund if you try GenF20 Plus for 60 days (two boxes) and are not satisfied. The fine print:
That is a real, written guarantee, and better than many in this category. But the clock starts at delivery, not when you open the first box, so if you plan to use the full 60 days, ship your return early and with tracking. To keep the refund option, decide by about day 55 so returns arrive within 67 days of delivery. The guarantee page does not mention purchases from other sellers, but it is reasonable to assume the company will only refund orders it can find in its own system.
| Green flags | Red flags |
|---|---|
| Long-running company with listed addresses and phone support | Headline "28%" claim comes from a post hoc subgroup |
| A published placebo-controlled trial of the actual product | Main result was not significant; no other outcomes beat placebo |
| Tablet ingredient amounts shown on the site | Oral spray ingredients not listed on the official site |
| Written 67-day guarantee | Strict terms: empty boxes, hard deadline, shipping not refunded |
| BBB accredited, A+ rating | "No known side effects" conflicts with its own trial data |
GenF20 Plus is legit in the sense that matters for avoiding a scam: a real company, a real product, a real guarantee and a published trial. What the trial does not do is prove the product raises growth hormone or delivers the benefits on the sales page. On its main measure it did not beat placebo, the 28% figure comes from an after-the-fact subgroup, and nothing else it measured improved compared with placebo.
If you want to try it, treat it as an experiment you can get your money back on, not as a substitute for medical care. Buy from the official site, keep your empty boxes and watch the 67-day deadline. If you have symptoms you think are hormone-related, see a doctor who can test for them. For our overall verdict on cost and value, read the full GenF20 Plus review.
Affiliate link: we earn a commission if you buy through it, at no extra cost to you. 67-day money-back guarantee: the two opened, empty boxes plus any unopened ones must reach the warehouse within 67 days of delivery; shipping isn't refunded, duties and taxes must be paid for a refund, and it's one refund per customer.